Fully automated radiosynthesis of [1-(2-[18F]fluoroethyl),1H[1, 2,3]triazole 4-ethylene] triphenylphosphonium bromide as a potential positron emission tomography tracer for imaging apoptosis

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 56, Issue 6, 2013, Pages 313-316

  Haslop, Anna ^a   Gee, Antony ^b   Plisson, Christophe ^c   Long, Nicholas ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Imanova Ltd   (United Kingdom)

Author keywords

apoptosis imaging; automated synthesis; fluoride; phosphonium salts

Indexed keywords

AUTOMATION; CELL DEATH; FLUORINE COMPOUNDS; POSITRON EMISSION TOMOGRAPHY; SALT DEPOSITS; SALTS;

APOPTOSIS IMAGING; AUTOMATED SYNTHESIS; AUTOMATED SYSTEMS; FLUORIDE; FLUORINE-18; FULLY AUTOMATED; IMAGING AGENT; PHOSPHONIUM SALTS; POTENTIAL IMAGING; RADIOSYNTHESIS;

FLUORINE;

COPPER; FLUORINE 18; PHOSPHONIUM DERIVATIVE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; [1 (2 [18F]FLUOROETHYL),1H[1,2,3]TRIAZOLE 4 ETHYLENE]TRIPHENYLPHOSPHONIUM BROMIDE;

APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; AUTOMATION; CHEMICAL REACTION; CYCLOADDITION; DRUG ACTIVITY; DRUG PURIFICATION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY;

APOPTOSIS IMAGING; AUTOMATED SYNTHESIS; FLUORIDE; PHOSPHONIUM SALTS;

APOPTOSIS; CHEMISTRY TECHNIQUES, SYNTHETIC; FLUORINE RADIOISOTOPES; ISOTOPE LABELING; ORGANOPHOSPHORUS COMPOUNDS; RADIOACTIVE TRACERS; TRIAZOLES;

EID: 84879177635     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.3024     Document Type: Article

References (22)

1. M. R. Duchen, Mol. Aspects Med. 2004, 25, 365-451.
2. M. P. Murphy, R. A. J. Smith, Adv. Drug Deliv. Rev. 2000, 41, 235-250.
3. I. Madar, Y. Huang, H. Ravert, S. L. Dalrymple, N. E. Davidson, J. T. Isaacs, R. F. Dannals, J. J. Frost, J. Nucl. Med. 2009, 50, 774-780.
4. T. Belhocine, N. Steinmetz, R. Hustinx, P. Bartsch, G. Jerusalem, L. Seidel, P. Rigo, A. Green, Clin. Cancer Res. 2002, 8, 2766-2774.
5. J. Hoglund, A. Shirvan, G. Antoni, S. A. Gustavsson, B. Langstrom, A. Ringheim, J. Sorensen, M. Ben-Ami, I. Ziv, J. Nucl. Med. 2011, 52, 720-725.
6. A. Reshef, A. Shirvan, R. N. Waterhouse, H. Grimberg, G. Levin, A. Cohen, L. G. Ulysse, G. Friedman, G. Antoni, I. Ziv, J. Nucl. Med. 2008, 49, 1520-1528.
7. F. G. Blankenberg, J. Nucl. Med. 2008, 49 (Suppl 2), 81S-95S.
8. M. G. Vander Heiden, N. S. Chandel, E. K. Williamson, P. T. Schumacker, C. B. Thompson, Cell 1997, 91, 627-637.
9. M. F. Ross, G. F. Kelso, F. H. Blaikie, A. M. James, H. M. Cocheme, A. Filipovska, T. Da Ros, T. R. Hurd, R. A. J. Smith, M. P. Murphy, Biochemistry-Moscow 2005, 70, 222-230.
10. S. S. Gambhir, Z. Cheng, Patent Application Publication, US, 2007; Vol. US2007/0092443 A1.
11. L. E. Bakeeva, L. L. Grinius, A. A. Jasaitis, V. V. Kuliene, D. O. Levitsky, E. A. Liberman, I. I. Severina, V. P. Skulachev, Biochim. Biophys. Acta 1970, 216, 13-21.
12. I. Madar, H. Ravert, B. Nelkin, M. Abro, M. Pomper, R. Dannals, J. J. Frost, Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 2057-2065.
13. J. J. Min, S. Biswal, C. Deroose, S. S. Gambhir, J. Nucl. Med. 2004, 45, 636-643.
14. J. D. Steichen, M. J. Weiss, D. R. Elmaleh, R. L. Martuza, J. Neurosurg. 1991, 74, 116-122.
15. V. V. Rostovtsev, L. G. Green, V. V. Fokin, K. B. Sharpless, Angew. Chem. Int. Ed. 2002, 41, 2596-2599.
16. R. A. Evans, Aust. J. Chem. 2007, 60, 384.
17. M. Glaser, E. Arstad, Bioconjug. Chem. 2007, 18, 989-993.
18. J. C. Wu, D. X. Wang, Z. T. Huang, M. X. Wang, J. Org. Chem. 2010, 75, 8604-8614.
19. N. Sugai, H. Heguri, K. Ohta, Q. Meng, T. Yamamoto, Y. Tezuka, J. Am. Chem. Soc. 2010, 132, 14790-14802.
20. R. Dharanipragada, G. Fodor, J. Chem. Soc., Perkin Trans. 1 1986, 545-550.
21. A. D. C. Parenty, L. V. Smith, L. Cronin, Tetrahedron 2005, 61, 8410-8418.
22. T. R. Chan, R. Hilgraf, K. B. Sharpless, V. V. Fokin, Org. Lett. 2004, 6, 2853-2855.